In short, we identified a set of candidate RBPs associated with HCC progression by performing bioinformatics analysis using well-established HCC datasets, and RPS5 was selected for further experimental validation due to its abundant expression and uncharacterized role in HCC. Here, RPS5 is linked to hepatocellular carcinoma.